Cliff Asness’s iBio IBIO Stock Holding History

Cliff Asness’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-266	Closed	-$205K	–	2255
2021 Q1	$205K	Sell	266 -50	-16%	-$43.6K	﹤0.01%	2107
2020 Q4	$166K	Sell	316 -22	-7%	-$17.9K	﹤0.01%	2110
2020 Q3	$343K	Buy	+338	New	+$490K	﹤0.01%	1871

Other funds holding IBIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Cliff Asness's IBIO Position: Q2 2021 in Review

Cliff Asness sold out of iBio (IBIO) in Q2 2021, closing a stake of 266 shares — an estimated $205K sold.

Cliff Asness first reported a position in IBIO in Q3 2020 and held it in 3 quarters. The position peaked at $343K in Q3 2020. 83 funds tracked by Wall St. Rank hold IBIO as of Q2 2021.

Cliff Asness reported no remaining iBio position as of Q2 2021 after selling out during the quarter.
Cliff Asness sold 266 iBio shares in Q2 2021, an estimated $205K.
Cliff Asness first reported a position in iBio in Q3 2020 and held it in 3 quarters.
Cliff Asness's iBio position peaked at $343K in Q3 2020.
83 funds tracked by Wall St. Rank held iBio as of Q2 2021.

Based on AQR Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.